Retrophin (RTRX) Tops Q3 EPS Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Retrophin (RTRX) Tops Q3 EPS Views

Retrophin Reports Third Quarter 2017 Financial Results

November 7, 2017 4:21 PM EST

SAN DIEGO, CALIFORNIA -- (Marketwired) -- 11/07/17 -- Retrophin, Inc. (NASDAQ: RTRX) today reported its third quarter 2017 financial results and provided a corporate update.

-- The Phase 3 FORT Study of fosmetpantotenate in pantothenate kinase- associated neurodegeneration (PKAN) remains on-track to complete enrollment in the second half of 2018 -- The Company received regulatory feedback on its Phase 3 protocol for sparsentan in FSGS; additional statistical analyses to be provided while trial start-up activities continue -- Net product sales for the third quarter of 2017 were $40.3 million, compared to $33.9 million for the same period in 2016 -- Cash, cash equivalents and... More